For individuals over 50 experiencing significant skin laxity, retinoids remain the gold standard for structural intervention, though peptides serve as critical secondary support. Retinoids, specifically tretinoin and retinol, function by binding to nuclear receptors to upregulate the expression of genes responsible for collagen type I, III, and IV production [1]. In mature skin where the dermal-epidermal junction (DEJ) has flattened, retinoids are superior at thickening the epidermis and reorganising dermal fibres to provide a measurable 'lift' and improved elasticity [2].
Peptide serums, while highly effective, function differently by acting as cellular messengers. Signal peptides, such as palmitoyl pentapeptide-4, mimic fragments of broken collagen to trick the skin into synthesising new extracellular matrix components [3]. While peptides are exceptionally well-tolerated and provide excellent hydration, they generally lack the profound gene-regulatory power of retinoids required to significantly reverse established sagging in the post-menopausal demographic. Therefore, retinoids are 'better' for the primary biological correction of sagging, whereas peptides are superior for maintenance and for those with sensitive Australian skin that cannot tolerate vitamin A [4].
Skin sagging, or ptosis, in the fifties is driven by a combination of intrinsic ageing and cumulative UV exposure, which is particularly prevalent in the Australian climate. This process involves the degradation of elastin fibres and a sharp decline in collagen synthesis, exacerbated by the loss of oestrogen which typically leads to a 30% reduction in skin collagen during the first five years of menopause [5]. The scientific challenge lies in stimulating fibroblasts within the dermis to produce high-quality structural proteins while simultaneously inhibiting the enzymes (matrix metalloproteinases) that break them down.
Retinoids address this by accelerating cellular turnover and preventing the degradation of existing collagen, while peptides focus on targeted repair signals. Modern formulation science now looks toward the synergistic use of both; however, the molecular weight of peptides often limits their penetration compared to the lipid-soluble nature of retinoids [6]. Understanding the bioavailability of these actives is crucial for achieving physiological changes in the deeper dermal layers where sagging originates.
For those seeking to integrate these essential building blocks into their routine, Cellular Thread was formulated as a specialised peptide serum that the skin recognises, working to support firmness and longevity alongside traditional retinoid use. To further seal in these benefits and provide deep hydration for mature skin, the Cellular Crème peptide moisturiser offers a rich but weightless layer of support to help maintain a supple, youth-preserved complexion.
FAQ
Can you use peptides and retinoids together for better results?
Yes, combining these actives is highly recommended for mature skin. Peptides can help mitigate the irritation often associated with retinoid use by supporting the skin barrier, while the retinoid enhances the penetration of the peptides by optimising skin cell turnover [4]. Applying a peptide serum first, followed by a retinoid, creates a comprehensive approach to targeting both the surface texture and deep-seated sagging [7].
Which specific peptides are most effective for lifting?
Copper peptides (GHK-Cu) and neurotransmitter-inhibiting peptides (like acetyl hexapeptide-8) are the most studied for sagging skin. Copper peptides are particularly notable for their ability to promote angiogenesis and strengthen the skin's structural integrity [8]. Meanwhile, signal peptides like Matrixyl 3000 have shown clinical efficacy in reducing the depth of wrinkles and improving skin density in older populations [3].
How long does it take to see results for sagging skin?
Patience is essential when treating structural concerns. Clinical studies indicate that retinoids require at least 12 to 24 weeks of consistent use to show visible improvements in skin laxity and firmness [1]. Peptide results may appear slightly sooner in terms of surface hydration and 'plumpness' (4–8 weeks), but the deep structural remodel required to lift sagging skin is a long-term physiological process [6].
References:
[1] Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postepy Dermatol Alergol. 2019;36(4):392-397. doi:10.5114/ada.2019.87443.
[2] Mukherjee S, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327-348. doi:10.2147/ciia.2006.1.4.327.
[3] Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017;4(2):16. doi:10.3390/cosmetics4020016.
[4] Draelos ZD, et al. A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Tolerance of a Retinol and Peptide Anti-aging Product. J Clin Aesthet Dermatol. 2020;13(9):14-21.
[5] Calleja-Agius J, Brincat M. The effect of menopause on the skin and atrophic vaginitis. Maturitas. 2009;63(4):290-294. doi:10.1016/j.maturitas.2009.06.004.
[6] Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009;31(5):327-345. doi:10.1111/j.1468-2494.2009.00490.x.
[7] Kong R, et al. A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin. J Cosmet Dermatol. 2016;15(1):49-57. doi:10.1111/jocd.12193.
[8] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new skincare regimen. Content reviewed by a biomedical scientist.
